| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |